Acadia Pharma EVP R&D Doug Williamson to depart; search for replacement underway

ACADIA PHARMACEUTICALS INC

Doug Williamson, MD, EVP Head of R&D, leaving Acadia to pursue other opportunities.
Williamson joined Acadia in January 2023 and will remain during a transitional period.
Company has initiated a search for a replacement EVP of Research and Development.
No financial impact or guidance changes disclosed in the filing.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.